Trastuzumab
In stock
Description
Trasturel 440 mg is a targeted biological therapy containing Trastuzumab. As a monoclonal antibody, it primarily treats HER2-positive breast and metastatic stomach cancers by binding to HER2 proteins, thereby inhibiting tumor cell growth and flagging cancer cells for immune system destruction
